Per the interpretation of results section of the instructions for use: "results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." per the limitations section of the instructions for use: "all in vitro assays can generate erroneous results, both clinically false positive results (test results suggesting a condition that is absent) and clinically false negative results (test results failing to identify a condition that is present)." "if an aberrant or abnormal result, as defined by the laboratory protocol, occurs, laboratory personnel should first make certain that the system is performing and is operated and maintained in accordance with the product labeling.The user should then follow the laboratory protocol for advising the clinician of a result that appears to have deviated from the norms established by the laboratory." "test results alone are not diagnoses of medical conditions.For example, low titer elevations of hcg can occur in normal non-pregnant subjects.A physician's diagnosis involves evaluation of the test result in conjunction with, and in the context of, the patient's medical history, physical examination, and other test results - sometimes in consultation with other medical experts." siemens investigation is complete.The customer reported a high discordant thcg patient result on 8/9/2019.The high result was questioned so the patient was redrawn and retested.The new draw resulted negative for thcg.No sample volume was remaining from the 8/9/2019 for repeat.No issues were reported with controls or other patient samples.This issue only affected the one draw from this patient.Siemens has reviewed this escalation and ruled out the assay as the cause of the discordant result.Siemens reviewed all the acquired log files from the atellica im analyzer.The logs did not contain any errors or abnormalities on the day of this incident that could help explain the elevated result.Based on the log review siemens cannot definitively determine the cause of this discrepant result., but cannot rule out sample integrity, and/or other preanalytical variables as contributing factors.However, quality controls samples were in range and no issues were noted with other patient samples, indicating that the instrument and reagents were performing acceptably.A systemic product non-conformance has not been identified.No further evaluation of the device is required.
|
A falsely elevated atellica im thcg result was obtained on (b)(6) 2019 using reagent lot 306 (kit lot 54207306).The physician questioned the result.The patient was redrawn and retested over the next two days.Both retest results were lower, as expected.A corrected report was issued based on the retest results.Although the customer indicated the prescribing of medication (isotretinoin) was delayed approximately one week because of this event, there was no report of adverse health consequences due to the initial discordant total hcg result.
|